ACRIX | CLTIX | ACRIX / CLTIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 11 years | - |
Gain YTD | 4.066 | 6.262 | 65% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000000 | 2500 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.35B | 25.4M | 5,315% |
Annual Yield % from dividends | 0.86 | 1.14 | 75% |
Returns for 1 year | 7.07 | 10.07 | 70% |
Returns for 3 years | 8.71 | -8.72 | -100% |
Returns for 5 years | 17.65 | 18.85 | 94% |
Returns for 10 years | N/A | 16.13 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CWIFX | 66.23 | 0.46 | +0.70% |
American Funds Capital World Gr&Inc 529F | |||
SRFMX | 14.66 | 0.09 | +0.62% |
Sarofim Equity | |||
RYVYX | 594.41 | 2.48 | +0.42% |
Rydex NASDAQ-100® 2x Strategy H | |||
DGIEX | 21.13 | 0.05 | +0.24% |
BNY Mellon Global Emerging Mkts - I | |||
EMGAX | 25.41 | -0.03 | -0.12% |
Allspring Emerging Markets Equity A |